Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.
Press releases published on April 1, 2025

COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order
TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and …

NowVertical Reports Record 2024 Financial Results
Company Hosting Investor Webinar on April 2, 2025, at 10:00 AM EST Q4 2024 revenue was $10.9 million, up 94% Y/Y excluding recent divestitures On a reported basis, Q4 2024 revenue increased 8% Y/Y Q4 2024 Net Income was $0.6 million, up 115% Y/Y excluding …

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …

Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée
Objectifs de recrutement dépassés avec 1.009 patients randomisés dans la cohorte principale et 411 dans la cohorte exploratoire Principaux résultats de NATiV3 attendus au deuxième semestre 2026 et, si positifs, ils supporteront les demandes règlementaires …

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that the Compensation and Human …

Castle Biosciences to Present New Data at EADO Supporting the Clinical Value of the DecisionDx®-Melanoma Test in Guiding Risk-Aligned Management of Patients with Melanoma
Two posters will share data on the significant risk stratification provided by DecisionDx-Melanoma in a real-world cohort of patients with stage IIB-IIC cutaneous melanoma (CM) to help guide adjuvant therapy, and the role of the test in prompting use of …

Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement
RAANANA, ISRAEL, April 01, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a biotech company specializing in innovative intranasal hydrogels, today announced the closing of its previously announce private placement of approximately …

nCino Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Q4 Total Revenues of $141.4M, up 14% year-over-year Fiscal Year 2025 Total Revenues of $540.7M, up 13% year-over-year Q4 Subscription Revenues of $125.0M, up 16% year-over-year Fiscal Year 2025 Subscription Revenues of $469.2M, up 15% year-over-year …

Jamf completes acquisition of Identity Automation, expanding its platform to include dynamic identity management for specific industries
MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, today announced it has completed the acquisition of Identity Automation, a dynamic identity and access management (IAM) platform for …

Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that company management will …

Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting
REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced 11 oral and poster …

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
SCOTTSDALE, Ariz., April 01, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical” or the “Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug …

Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that on March 23, 2025, the compensation committee of Biomea’s …

AI-Media s’associe à AudioShake pour révolutionner l’audio des sports en direct et la traduction vocale alimentée par l’IA
NEW YORK, 01 avr. 2025 (GLOBE NEWSWIRE) -- AI-Media, leader mondial des technologies et solutions linguistiques alimentées par l’IA, est ravi d’annoncer un partenariat stratégique avec AudioShake, une entreprise pionnière en technologie audio spécialisée …

AI-Media משתפת פעולה עם AudioShake כדי לחולל מהפכה עבור שמע בשידורי ספורט חיים ותרגום קולי מבוסס בינה מלאכותית
ניו יורק, April 01, 2025 (GLOBE NEWSWIRE) -- AI-Media, מובילה עולמית בפתרונות תרגום וכתוביות מבוססי בינה מלאכותית, נרגשת להכריז על שותפות מתקדמת עם AudioShake, חברת טכנולוגיית שמע פורצת דרך המתמחה בהפרדת קולות. שותפות זו תשפר את הפתרון LEXI Voice של AI- …

AI-Media Bermitra dengan AudioShake untuk Merevolusi Audio Acara Olahraga Langsung dan Penerjemahan Suara AI
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- AI-Media, pemimpin global dalam teknologi dan solusi bahasa yang didukung AI, dengan senang hati mengumumkan kemitraan lanjutan dengan AudioShake, perusahaan teknologi audio perintis yang memiliki spesialisasi …

AI-Media, AudioShake와 손잡고 라이브 스포츠 오디오 및 AI 음성 번역 혁신 창출에 나서다
뉴욕, April 02, 2025 (GLOBE NEWSWIRE) -- AI 기반 언어 기술 및 솔루션 분야를 선도하는 AI-Media 가 사운드 분리 전문 오디오 기술 회사인 AudioShake와 한층 진척된 전략적 파트너십을 추진한다고 발표했다. 이번 파트너십을 통해 AI-Media의 LEXI Voice솔루션은 실시간 AI 음성 번역을 통해 완전 자동화된 고품질 믹스를 생성하여 라이브 방송 오디오의 새로운 업계 표준을 제시할 것으로 기대된다. …

AI-Media จับมือกับ AudioShake เพื่อปฏิวัติระบบเสียงด้านการถ่ายทอดสดกีฬาและการแปลคำพูดด้วย AI
นิวยอร์ก, April 02, 2025 (GLOBE NEWSWIRE) -- AI-Media ผู้นำด้านเทคโนโลยีและโซลูชันเกี่ยวกับภาษาผ่าน AI ระดับโลกรู้สึกตื่นเต้นอย่างยิ่งที่จะประกาศความร่วมมือในระดับสูงกับ AudioShake บริษัทเทคโนโลยีด้านเสียงชั้นนำที่เชี่ยวชาญด้านการแยกเสียง …

AI-Media 携手 AudioShake 共同革新体育赛事直播音频及 AI 语音翻译
纽约, April 02, 2025 (GLOBE NEWSWIRE) -- 全球领先的 AI 语言技术和解决方案提供商 AI-Media 欣然宣布与专注于声音分离技术的创新音频技术公司 AudioShake 达成深度合作。 这一合作将进一步增强 AI-Media 的 LEXI Voice 解决方案,实现全自动、高质量的 AI 语音实时翻译混音,为现场直播音频树立新行业标准。 AudioShake 的尖端技术能够在嘈杂的环境(如体育赛事、音乐会和新闻直播)中精准分离人声。 借助这一能力,AI-Media …

AI-Media 與 AudioShake 合作,徹底改變現場體育音頻和 AI 語音翻譯
紐約, April 02, 2025 (GLOBE NEWSWIRE) -- 全球領先的 AI 驅動語言技術與解決方案提供商 AI-Media,欣然宣布與 AudioShake 建立先進的合作夥伴關係,該公司專注於音頻技術和聲音分離。 這項合作將增強 AI-Media 的 LEXI Voice 解決方案,創造一個完全自動化的優質混音,並提供實時 AI 語音翻譯,為現場電台廣播音頻樹立全新行業標準。 AudioShake 的尖端技術能夠在現場體育賽事、音樂會和新聞直播等嘈吵環境中有效分離對話。 這項能力將使 …